Research remains at the core
VTT spinouts increased their research and development spending by 29% in 2024 compared with the previous year. Most of their employees worked in R&D, and around a quarter held doctoral degrees.
These companies commercialise technologies developed at VTT Technical Research Centre of Finland, with activities spanning quantum technology, energy and biotechnology.
Building beyond the laboratory
The analysis combines company financial and funding data with Statistics Finland’s register data. It highlights the importance of patient financing: early funding supports further research, product development and specialist recruitment as companies work towards commercial scale.
SourceVTT
